A New HIV Vaccine Could Protect Patients Against Multiple Viral Strains
A new HIV vaccine is moving into a Phase IIb trial and could potentially protect…
A new HIV vaccine is moving into a Phase IIb trial and could potentially protect…
ViiV Healthcare obtained positive Phase III results for its two-drug HIV treatment regimen, which could…
In the process of studying HIV-infected patients who naturally don’t need therapy to…
TC Biopharm has partnered with Scotia Biologics to produce tumor-specific antibodies for a new generation…
HIV research has come a long way since the disease was discovered in the 1980s.…
A report on the use of biosensors in molecular disease diagnostics states the technology could…
Clara chatted with Christian Setz, CEO of Immunologik, to find out how the company is…
ViiV Healthcare has just started a clinical trial to test if its two-drug regimen for…
Phase IIa data confirms that Abivax’s potential HIV cure not only reduces viral reservoir but…
While treating an HIV-infected patient for lung cancer, a cancer drug caused a “drastic and…
In the early stages of infection, the immune system might be able to stop HIV.…
We've taken a break from travelling and come home to Berlin this week. Here, we…